Medical/Pharmaceuticals

PharmaBlock Appointed Dr. Wenfang Miao as Chief Executive Officer

NANJING, China, Nov. 29, 2021 /PRNewswire/ -- PharmaBlock (300725.SZSE), an innovative chemistry products and services provider to support drug discovery, development, and commercialization, announced today that the former Senior Vice President of Quality, Dr.Wenfang Miao, is appointed as the com...

2021-11-29 20:00 3416

ST Pharm announces expansion of oligonucleotide facility, taking a leap towards the world's largest oligonucleotide CDMO

SEOUL, South Korea, Nov. 29, 2021 /PRNewswire/ -- On November 24, ST Pharm Co. Ltd., an API CDMO company in Republic of Korea, announced to build the second oligonucleotide manufacturing plant for an expansion of production facilities and to preoccupy the rapidly growing oligonucleotide therapeut...

2021-11-29 20:00 3125

Concord Medical Schedules 2020 Annual Meeting of Shareholders

BEIJING, Nov. 29, 2021 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research and prevention by operating a network of medically advanced comprehensive cancer hospitals and standalone ...

2021-11-29 19:25 2978

Ascentage Pharma Appoints Mr. Yiqing Chen as Chief Financial Officer

SUZHOU, China, and ROCKVILLE, MD., Nov. 29, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced the appointment of Mr.Yiqing Chen as Chief Financ...

2021-11-29 19:01 2858

Hummingbird Bioscience Appoints Jan Møller Mikkelsen as Chairman of the Board

HOUSTON and SINGAPORE, Nov. 29, 2021 /PRNewswire/ -- Hummingbird Bioscience Holdings Limited, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets in cancer and autoimmune disease, today announced the appointment of Jan Møller Mikkels...

2021-11-29 17:00 2663

Help Therapeutics Completes Series C Financing of 25 Million Dollars

NANJING, China, Nov. 29, 2021 /PRNewswire/ -- Recently, the iPSC therapeutics leading global platform company -Help Therapeutics announced the completion of Series C financing of 25 millions of dollars. This round of financing was led by Ming Bioventures, followed by Share Capital, Beisen Medical...

2021-11-29 16:25 2136

Tigermed Recognized with Frost & Sullivan 2021 China Clinical CRO Competitive Strategy Leadership Award

HANGZHOU, China, Nov. 29, 2021 /PRNewswire/ -- Tigermed, a leading provider of innovative clinical research solutions for biopharmaceutical and medical device industry, announced that it has been awarded the Frost & Sullivan 2021 China Contract Research Organization (CRO) Competitive Strategy Lea...

2021-11-29 15:27 3005

Ablaze Pharmaceuticals Launches with $75m Series A Financing to Bring Novel Targeted Radiopharmaceuticals to Treat Cancer Patients in the Greater China Market

SHANGHAI and SAN DIEGO, Nov. 29, 2021 /PRNewswire/ -- Ablaze Pharmaceuticals ("Ablaze"), a clinical-stage pharmaceutical company focused on the development and commercialization of innovative targeted radiopharmaceutical therapies (TRT) against tumor targets, announced a$75 million Series A finan...

2021-11-29 10:00 5120

VISTA Eye Specialist Shares How It Thrives during the COVID-19 Pandemic

PETALING JAYA, Malaysia, Nov. 29, 2021 /PRNewswire/ -- As part of VISTA Eye Specialists' (VISTA) core value of 'Giving Back to the Community', VISTA does not only give for charity, but believes strongly in sharing of knowledge and experiences. Other than sharing via conferences and publications, ...

2021-11-29 09:40 3479

Tang Prize Laureates Reflect on the Breakthroughs Made Possible by Cytokine Research

TAIPEI, Nov. 27, 2021 /PRNewswire/ -- Following the inspiring opening speech, "Future Perspective of Cancer Immunotherapy," delivered by Nobel Prize and Tang Prize laureate Prof.Tasuku Honjo at the 14th Asia Pacific Federation of Pharmacologist Conference (APFP) onNovember 26, the 2020 Tang Prize...

2021-11-27 16:00 5754

Tang Prize Laureates Reflect on the Breakthroughs Made Possible by Cytokine Research

TAIPEI, Nov. 27, 2021 /PRNewswire/ -- Following the inspiring opening speech, "Future Perspective of Cancer Immunotherapy," delivered by Nobel Prize and Tang Prize laureate Prof.Tasuku Honjo at the 14th Asia Pacific Federation of Pharmacologist Conference (APFP) onNovember 26, the 2020 Tang Prize...

2021-11-27 16:00 5370

ASUS and Medical Professionals Showcase Five Smart Healthcare Achievements

SINGAPORE, Nov. 26, 2021 /PRNewswire/ -- ASUS Intelligent Cloud Services (AICS) today introduced five smart medical solutions during its AICS Medical Open House. The xHIS platform, the Lumos EMR search platform, the Drug Safety Service, the Miraico smart medical coding assistant and the Personal ...

2021-11-26 21:47 6806

Australian biotech company Starpharma announces positive interim results from the prostate cancer cohort in its ongoing phase 2 trial of DEP® cabazitaxel

MELBOURNE, Australia, Nov. 26, 2021 /PRNewswire/ -- Starpharma showed that 100% of evaluable patients with Stage IV prostate cancer have had efficacy responses, utilising one or more standard measures of disease. DEP® cabazitaxel  is a patent...

2021-11-26 17:34 4157

Róbert Wessman-led Aztiq and Innobic join forces in $475m acquisition of Lotus Pharmaceutical and Adalvo to create a global pharmaceutical powerhouse

REYKJAVÍK, Iceland, Nov. 26, 2021 /PRNewswire/ -- Aztiq   ("Aztiq"), a healthcare investor led by Alvogen Founder and Chairman Róbert Wessman, andInnobic (Asia) Company Limited ("Innobic"), a life sciences subsi...

2021-11-26 15:51 3979

Starpharma releases positive DEP® phase 2 interim results in prostate cancer

MELBOURNE, Australia, Nov. 26, 2021 /PRNewswire/ -- Melbourne biotech company Starpharma today announced positive interim results from the prostate cancer cohort in its ongoing phase 2 trial of DEP® cabazitaxel. The company showed that 100% of evaluable patients with (Stage IV) metastatic prostat...

2021-11-26 15:41 3038

Premium Red Ginseng Brand CheongKwanJang to Celebrate 122nd anniversary

SEOUL, South Korea, Nov. 26, 2021 /PRNewswire/ -- Korea Ginseng Corp (KGC) celebrates the 122nd anniversary of its premium red ginseng brand, CheongKwanJang. Red Ginseng One of the best ginseng in the world, Korean ginseng became a premi...

2021-11-26 15:37 4798

Premium Red Ginseng Brand CheongKwanJang to Celebrate 122nd anniversary

SEOUL, South Korea, Nov. 26, 2021 /PRNewswire/ -- Korea Ginseng Corp (KGC) celebrates the 122nd anniversary of its premium red ginseng brand, CheongKwanJang. Korean Ginseng One of the best ginseng in the world, Korean ginseng became a...

2021-11-26 15:28 5909

Antengene Included in the MSCI Global Small Cap Indexes - MSCI China Index Constituent Stocks

SHANGHAI and HONG KONG, Nov. 26, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hematology and onco...

2021-11-26 11:34 5245

IASO Biotheraputics' CT120 Granted Orphan Drug Designation by the U.S. FDA

SAN JOSE, Calif., NANJING, China and SHANGHAI, Nov. 25, 2021 /PRNewswire/ -- IASO Biotherapeutics (IASO Bio), a clinical-stage biopharmaceutical company focusing on discovering, developing, and manufacturing innovative medicine announcedon Oct 26, 2021 that the Office of Orphan Products Developme...

2021-11-26 11:05 2437

Medical AI Provider Lunit Raises $61M in Funding Round Led By Major Global Healthcare Investors

- New investors include US life science investors HealthQuest Capital, Casdin Capital, and American Cancer Society BrightEdge, andAsia-based global healthcare investors Tybourne Capital Management and NSG Ventures - Following the most recent strategic investment of $26 million from Guardant Heal...

2021-11-25 22:00 4133
1 ... 617618619620621622623 ... 643